Common Comorbid Condition of Patients With Autism Spectrum Disorder and Pharmacotherapy for Patients With Autism Spectrum Disorder

Overview

Journal Soa Chongsonyon Chongsin Uihak

Date 2024 Jan 11

PMID 38204750

Authors

Un Sun Chung

Ji-Hoon Kim

Affiliations

Soon will be listed here.

Abstract

This article describes common comorbid condtion of the autism spectrum disorder (ASD) and recommends treatment guidelines of pharmacotherapy for patients with ASD. More than 95% of people with ASD have at least one additional disorder and guidelines how to evaluate and treat comorbid conditions in patients with ASD and 7 recommendations for treatment with medication for ASD.

Citing Articles

Understanding Evidence-Based Practice for Autism Spectrum Disorder: Korean Practice Clinical Guidelines.

Yoo H Soa Chongsonyon Chongsin Uihak. 2024; 35(1):1.

PMID: 38204747 PMC: 10774560. DOI: 10.5765/jkacap.230076.

References

Ichikawa H, Mikami K, Okada T, Yamashita Y, Ishizaki Y, Tomoda A . Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study. Child Psychiatry Hum Dev. 2016; 48(5):796-806. PMC: 5617873. DOI: 10.1007/s10578-016-0704-x. View

Fuentes J, Hervas A, Howlin P . ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment. Eur Child Adolesc Psychiatry. 2020; 30(6):961-984. PMC: 8140956. DOI: 10.1007/s00787-020-01587-4. View

McDougle C, Scahill L, Aman M, McCracken J, Tierney E, Davies M . Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005; 162(6):1142-8. DOI: 10.1176/appi.ajp.162.6.1142. View

Hellings J, Weckbaugh M, Nickel E, Cain S, Zarcone J, Reese R . A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2005; 15(4):682-92. DOI: 10.1089/cap.2005.15.682. View

Wink L, Adams R, Wang Z, Klaunig J, Plawecki M, Posey D . A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Mol Autism. 2016; 7:26. PMC: 4839099. DOI: 10.1186/s13229-016-0088-6. View

Leyfer O, Folstein S, Bacalman S, Davis N, Dinh E, Morgan J . Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord. 2006; 36(7):849-61. DOI: 10.1007/s10803-006-0123-0. View

Goel R, Hong J, Findling R, Ji N . An update on pharmacotherapy of autism spectrum disorder in children and adolescents. Int Rev Psychiatry. 2018; 30(1):78-95. DOI: 10.1080/09540261.2018.1458706. View

. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005; 62(11):1266-74. DOI: 10.1001/archpsyc.62.11.1266. View

Williams K, Wray J, Wheeler D . Intravenous secretin for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2012; (4):CD003495. PMC: 7154585. DOI: 10.1002/14651858.CD003495.pub3. View

10.

Mason D, Ingham B, Urbanowicz A, Michael C, Birtles H, Woodbury-Smith M . A Systematic Review of What Barriers and Facilitators Prevent and Enable Physical Healthcare Services Access for Autistic Adults. J Autism Dev Disord. 2019; 49(8):3387-3400. PMC: 6647496. DOI: 10.1007/s10803-019-04049-2. View

11.

Marcus R, Owen R, Kamen L, Manos G, McQuade R, Carson W . A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009; 48(11):1110-1119. DOI: 10.1097/CHI.0b013e3181b76658. View

12.

Fombonne E, Goin-Kochel R, ORoak B . Beliefs in vaccine as causes of autism among SPARK cohort caregivers. Vaccine. 2020; 38(7):1794-1803. PMC: 10515441. DOI: 10.1016/j.vaccine.2019.12.026. View

13.

Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D . Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. J Sleep Res. 2012; 21(6):700-9. DOI: 10.1111/j.1365-2869.2012.01021.x. View

14.

Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J . Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology. 2009; 35(4):990-8. PMC: 2846602. DOI: 10.1038/npp.2009.202. View

15.

Williams K, Brignell A, Randall M, Silove N, Hazell P . Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2013; (8):CD004677. DOI: 10.1002/14651858.CD004677.pub3. View

16.

Kent J, Kushner S, Ning X, Karcher K, Ness S, Aman M . Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study. J Autism Dev Disord. 2012; 43(8):1773-83. DOI: 10.1007/s10803-012-1723-5. View

17.

Minshawi N, Wink L, Shaffer R, Plawecki M, Posey D, Liu H . A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders. Mol Autism. 2016; 7:2. PMC: 4712595. DOI: 10.1186/s13229-015-0062-8. View

18.

Rosen T, Mazefsky C, Vasa R, Lerner M . Co-occurring psychiatric conditions in autism spectrum disorder. Int Rev Psychiatry. 2018; 30(1):40-61. DOI: 10.1080/09540261.2018.1450229. View

19.

Kim H, Park E, Kim J, Boon-Yasidhi V, Tarugsa J, Reyes A . Aripiprazole for Irritability in Asian Children and Adolescents with Autistic Disorder: A 12-Week, Multinational, Multicenter, Prospective Open-Label Study. J Child Adolesc Psychopharmacol. 2018; 28(6):402-408. DOI: 10.1089/cap.2017.0152. View

20.

Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M . Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014; 53(2):237-57. DOI: 10.1016/j.jaac.2013.10.013. View